Overadditive anti-proliferative and pro-apoptotic effects of a combination therapy on colorectal carcinoma cells

  • Authors:
    • Christoph Herold
    • M. Ganslmayer
    • M. Ocker
    • S. Blauberger
    • S. Zopf
    • E. G. Hahn
    • D. Schuppan
  • View Affiliations

  • Published online on: September 1, 2003     https://doi.org/10.3892/ijo.23.3.751
  • Pages: 751-756
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The prognosis of advanced colorectal carcinoma (CC) is poor. Established chemotherapy shows only limited efficacy but significant side effects. We investigated how far a combination of tamoxifen (TAM), 9-cis-retinoic acid (CRA) and the fluoroquinolone ciprofloxacin (CIP) synergize to inhibit proliferation and promote apoptosis of CC cells in vitro. The CC cell lines LOVO, CC-531 and SW-403 were incubated with TAM, CRA and CIP (10minus;4-10minus;6 M) as single agents and in combination. Cell proliferation was assessed by bromodeoxyuridin incorporation. Apoptosis was quantified immunohistochemically and by FACS analysis after staining with propidium iodide. Changes in the expression of caspase 3, bax, bcl-2 and p21cip/waf were assessed by quantitative Western blotting. CRA and TAM monotherapy was moderately effective. Their combination enhanced apoptosis from 60% to more than 80% in all cell types. Apoptosis was paralleled by inhibition of proliferation and further potentiated by addition of CIP. The combination effectively up-regulated caspase 3 and bax and down-regulated bcl-2 and p21cip/waf. Combinations of biomodulaters act synergistically to inhibit proliferation and promote apoptosis in CC cells. Due to their known safety profile, this justifies clinical trials for colorectal cancer using combinations of these biological response modifiers.

Related Articles

Journal Cover

September 2003
Volume 23 Issue 3

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Herold C, Ganslmayer M, Ocker M, Blauberger S, Zopf S, Hahn EG and Schuppan D: Overadditive anti-proliferative and pro-apoptotic effects of a combination therapy on colorectal carcinoma cells. Int J Oncol 23: 751-756, 2003.
APA
Herold, C., Ganslmayer, M., Ocker, M., Blauberger, S., Zopf, S., Hahn, E.G., & Schuppan, D. (2003). Overadditive anti-proliferative and pro-apoptotic effects of a combination therapy on colorectal carcinoma cells. International Journal of Oncology, 23, 751-756. https://doi.org/10.3892/ijo.23.3.751
MLA
Herold, C., Ganslmayer, M., Ocker, M., Blauberger, S., Zopf, S., Hahn, E. G., Schuppan, D."Overadditive anti-proliferative and pro-apoptotic effects of a combination therapy on colorectal carcinoma cells". International Journal of Oncology 23.3 (2003): 751-756.
Chicago
Herold, C., Ganslmayer, M., Ocker, M., Blauberger, S., Zopf, S., Hahn, E. G., Schuppan, D."Overadditive anti-proliferative and pro-apoptotic effects of a combination therapy on colorectal carcinoma cells". International Journal of Oncology 23, no. 3 (2003): 751-756. https://doi.org/10.3892/ijo.23.3.751